Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Biotechnology

Healthcare
$18.31 +0.58%

+$0.10 today

Market cap
$980.14M
Beta
0.00
52W Low $14.85High $23.00

Volume 0.68M

Average 0.41M

SPTX Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

No reported Gross Profit figures are available to summarize.

Gross Profit history

Currency unavailable · from the income statement

No Gross Profit data reported for this period type.

Gross Profit vs competitors

How SPTX compares with its peers on the latest reported figures

SPTX Competitors
Gross Profit for SPTX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
VNDAVanda Pharmaceuticals Inc.LTM Mar 2026$201.36M USD+7.0%-4.1%92.5%
RAPPRapport Therapeutics, Inc. Common StockLTM Mar 2026$19M USD+2140.8%—95.0%
CTNMContineum Therapeutics, Inc. Class A Common StockLTM Mar 2026-$79K USD———
LBRXLB Pharmaceuticals Inc Common StockLTM Mar 2026-$82K USD———
GHRSGH Research PLCLTM Mar 2026-$268K USD———
MPLTMapLight Therapeutics, Inc.LTM Mar 2026-$574K USD-69.3%——
NMRANeumora Therapeutics, Inc. Common StockLTM Mar 2026-$5.01M USD———
SPTXSeaport Therapeutics, Inc. Common Stock—— ———
Peer median (excluding SPTX) —+7.0%-4.1%93.7%

Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Intrinsic Alpha fair value

Locked

Current Price

$18.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.